Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 13,046 shares at $32.79 ($428K) on 2025-01-16, disclosed to the SEC on 2025-01-17.
Seasonal sale ($428k) by EVP, Chf Clinical Develop Ofcr — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.79 | 6,523 | $214K | 50.0% |
| 2 | $32.79 | 6,523 | $214K | 50.0% |
| Total | $32.79 avg | 13,046 | $428K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |